We report a 64-year-old male with diabetes and chronic deep vein thrombosis (DVT) on warfarin who developed pulmonary hemorrhage, acute kidney injury (AKI), and markedly elevated cytoplasmic anti-neutrophil cytoplasmic antibody (c-ANCA) levels shortly after increasing his tirzepatide dose. This evidence concerns the gene PRTN3 and acute kidney injury.